471 related articles for article (PubMed ID: 21351624)
41. Platelet-rich plasma: growth factors and pro- and anti-inflammatory properties.
El-Sharkawy H; Kantarci A; Deady J; Hasturk H; Liu H; Alshahat M; Van Dyke TE
J Periodontol; 2007 Apr; 78(4):661-9. PubMed ID: 17397313
[TBL] [Abstract][Full Text] [Related]
42. [Analysis of angiogenesis related proteins and its implication in type-2 hereditary hemorrhagic telangiectasia].
Peng HL; Hu GY; Zhang GS; Gong FJ
Zhonghua Xue Ye Xue Za Zhi; 2006 Sep; 27(9):616-20. PubMed ID: 17278429
[TBL] [Abstract][Full Text] [Related]
43. Platelet-rich preparations to improve healing. Part II: platelet activation and enrichment, leukocyte inclusion, and other selection criteria.
Davis VL; Abukabda AB; Radio NM; Witt-Enderby PA; Clafshenkel WP; Cairone JV; Rutkowski JL
J Oral Implantol; 2014 Aug; 40(4):511-21. PubMed ID: 25106017
[TBL] [Abstract][Full Text] [Related]
44. Autologous concentrated platelet-rich plasma (cPRP) for local application in bone regeneration.
Dugrillon A; Eichler H; Kern S; Klüter H
Int J Oral Maxillofac Surg; 2002 Dec; 31(6):615-9. PubMed ID: 12521317
[TBL] [Abstract][Full Text] [Related]
45. Counting of platelet derived growth factor and transforming growth factor-beta in platelet-rich-plasma used in jaw bone regeneration.
Tonelli P; Mannelli D; Brancato L; Cinotti S; Morfini M
Minerva Stomatol; 2005; 54(1-2):23-34. PubMed ID: 15902060
[TBL] [Abstract][Full Text] [Related]
46. [Experimental research on the effects of different activators on the formation of platelet-rich gel and the release of bioactive substances in human platelet-rich plasma].
Yang Y; Zhang W; Cheng B
Zhonghua Shao Shang Za Zhi; 2017 Jan; 33(1):12-17. PubMed ID: 28103989
[No Abstract] [Full Text] [Related]
47. Effect of platelet-rich plasma on migration and proliferation of SaOS-2 osteoblasts: role of platelet-derived growth factor and transforming growth factor-beta.
Celotti F; Colciago A; Negri-Cesi P; Pravettoni A; Zaninetti R; Sacchi MC
Wound Repair Regen; 2006; 14(2):195-202. PubMed ID: 16630109
[TBL] [Abstract][Full Text] [Related]
48. Characterization and comparison of 5 platelet-rich plasma preparations in a single-donor model.
Magalon J; Bausset O; Serratrice N; Giraudo L; Aboudou H; Veran J; Magalon G; Dignat-Georges F; Sabatier F
Arthroscopy; 2014 May; 30(5):629-38. PubMed ID: 24725317
[TBL] [Abstract][Full Text] [Related]
49. Analysis and comparison of autologous platelet-rich plasma preparation systems used in the treatment of enthesopathies: A preliminary study.
Dejnek M; Moreira H; Płaczkowska S; Morasiewicz P; Barg E; Witkowski J; Reichert P
Adv Clin Exp Med; 2021 Jul; 30(7):757-764. PubMed ID: 34118138
[TBL] [Abstract][Full Text] [Related]
50. Correlation of plasma and serum vascular endothelial growth factor levels with platelet count in colorectal cancer: clinical evidence of platelet scavenging?
George ML; Eccles SA; Tutton MG; Abulafi AM; Swift RI
Clin Cancer Res; 2000 Aug; 6(8):3147-52. PubMed ID: 10955796
[TBL] [Abstract][Full Text] [Related]
51. Effects of the breed, sex and age on cellular content and growth factor release from equine pure-platelet rich plasma and pure-platelet rich gel.
Giraldo CE; López C; Álvarez ME; Samudio IJ; Prades M; Carmona JU
BMC Vet Res; 2013 Feb; 9():29. PubMed ID: 23402541
[TBL] [Abstract][Full Text] [Related]
52. The systemic effects of platelet-rich plasma injection.
Wasterlain AS; Braun HJ; Harris AH; Kim HJ; Dragoo JL
Am J Sports Med; 2013 Jan; 41(1):186-93. PubMed ID: 23211708
[TBL] [Abstract][Full Text] [Related]
53. Quantification of Growth Factors and Fibronectin in Diverse Preparations of Platelet-Rich Plasma for the Treatment of Ocular Surface Disorders (E-PRP).
Rodriguez AE; Gisbert S; Palazón A; Alio JL
Transl Vis Sci Technol; 2020 May; 9(6):22. PubMed ID: 32821519
[TBL] [Abstract][Full Text] [Related]
54. Exercise and the platelet activator calcium chloride both influence the growth factor content of platelet-rich plasma (PRP): overlooked biochemical factors that could influence PRP treatment.
Hamilton B; Tol JL; Knez W; Chalabi H
Br J Sports Med; 2015 Jul; 49(14):957-60. PubMed ID: 23770705
[TBL] [Abstract][Full Text] [Related]
55. Enhanced vascularization by controlled release of platelet-rich plasma impregnated in biodegradable gelatin hydrogel.
Kurita J; Miyamoto M; Ishii Y; Aoyama J; Takagi G; Naito Z; Tabata Y; Ochi M; Shimizu K
Ann Thorac Surg; 2011 Sep; 92(3):837-44; discussion 844. PubMed ID: 21871267
[TBL] [Abstract][Full Text] [Related]
56. Sustained or higher levels of growth factors in platelet-rich plasma during 7-day storage.
Wen YH; Lin WY; Lin CJ; Sun YC; Chang PY; Wang HY; Lu JJ; Yeh WL; Chiueh TS
Clin Chim Acta; 2018 Aug; 483():89-93. PubMed ID: 29684380
[TBL] [Abstract][Full Text] [Related]
57. Matrix metalloproteinase content and activity in low-platelet, low-leukocyte and high-platelet, high-leukocyte platelet rich plasma (PRP) and the biologic response to PRP by human ligament fibroblasts.
Pifer MA; Maerz T; Baker KC; Anderson K
Am J Sports Med; 2014 May; 42(5):1211-8. PubMed ID: 24627579
[TBL] [Abstract][Full Text] [Related]
58. Characteristics of canine platelet-rich plasma prepared with five commercially available systems.
Franklin SP; Garner BC; Cook JL
Am J Vet Res; 2015 Sep; 76(9):822-7. PubMed ID: 26309111
[TBL] [Abstract][Full Text] [Related]
59. Extracellular accumulation of bioactive substances during preparation and storage of various platelet concentrates.
Edvardsen L; Taaning E; Dreier B; Christensen LD; Mynster T; Nielsen HJ
Am J Hematol; 2001 Jul; 67(3):157-62. PubMed ID: 11391711
[TBL] [Abstract][Full Text] [Related]
60. Platelet rich plasma improves the healing process after airway anastomosis.
Gómez-Caro A; Ausin P; Boada M
Interact Cardiovasc Thorac Surg; 2011 Dec; 13(6):552-6. PubMed ID: 21835846
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
